Sentences with phrase «conditioning program with»

Meanwhile, Alumbaugh remains emphatically devoted to the duties he has now, which are many, including the beginning of a new strength and conditioning program with returning players early in 2013.

Lebert Fitness Youth Strength and Conditioning shows three Strength and Conditioning programs with the EQUALIZER ™ and BUDDY SYSTEM ™.

Not exact matches

Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.

The program will be offered to patients with chronic conditions such as type 2 diabetes, heart and gastrointestinal disease, depression, eating disorders and substance use disorders.

Ryan responded that the state programs that receive the waiver would sufficiently cover people with pre-existing conditions.

One of his experiments — related to the concept of basic income, in which every resident regularly receives a sum of money with no conditions attached — is a program that gives 100 people in Oakland, California, $ 1,000 to $ 2,000 a month.

However, progression of the condition can be properly controlled with interventions like those provided by Omada and the YMCA, which worked with the Centers for Medicare and Medicaid Innovation on the trial program.

During an interview with the conservative talk - radio host CL Bryant on Thursday, Louisiana Sen. Bill Cassidy said that while states could develop programs of their own, the bill mandated fair coverage for people with preexisting conditions.

That includes $ 15 million for inclusive education programs for children with special needs, and adds another $ 10 million to implement recommendations from the Council to Improve Classroom Conditions.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tprograms; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tPrograms (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tprograms; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

In addition to writing compelling blog posts about exercise techniques and healthy living (one example: «The Single Biggest Mistake Most People Make With Their Programs»), Gentilcore's site provides a veritable library of fitness, conditioning, and nutritional information.

I have asked the government to buy the property, but the state has not funded the program and I have no other recourse but to pull the equity out or lose it to depreciating marketplace conditions and the flooding stigma associated with it.

For the purposes of this section, «internal purposes» shall include the conduct of surveys, marketing studies and promotional activities, program planning, evaluation and audits for the Asia Pacific Foundation of Canada, the monitoring of compliance with the terms and conditions of use and the privacy policy set out in this legal notice, and upon notice to the User, editorial and feedback purposes.

Such risks and uncertainties include, but are not limited to: our ability to achieve our financial, strategic and operational plans or initiatives; our ability to predict and manage medical costs and price effectively and develop and maintain good relationships with physicians, hospitals and other health care providers; the impact of modifications to our operations and processes; our ability to identify potential strategic acquisitions or transactions and realize the expected benefits of such transactions, including with respect to the Merger; the substantial level of government regulation over our business and the potential effects of new laws or regulations or changes in existing laws or regulations; the outcome of litigation, regulatory audits, investigations, actions and / or guaranty fund assessments; uncertainties surrounding participation in government - sponsored programs such as Medicare; the effectiveness and security of our information technology and other business systems; unfavorable industry, economic or political conditions, including foreign currency movements; acts of war, terrorism, natural disasters or pandemics; our ability to obtain shareholder or regulatory approvals required for the Merger or the requirement to accept conditions that could reduce the anticipated benefits of the Merger as a condition to obtaining regulatory approvals; a longer time than anticipated to consummate the proposed Merger; problems regarding the successful integration of the businesses of Express Scripts and Cigna; unexpected costs regarding the proposed Merger; diversion of management's attention from ongoing business operations and opportunities during the pendency of the Merger; potential litigation associated with the proposed Merger; the ability to retain key personnel; the availability of financing, including relating to the proposed Merger; effects on the businesses as a result of uncertainty surrounding the proposed Merger; as well as more specific risks and uncertainties discussed in our most recent report on Form 10 - K and subsequent reports on Forms 10 - Q and 8 - K available on the Investor Relations section of www.cigna.com as well as on Express Scripts» most recent report on Form 10 - K and subsequent reports on Forms 10 - Q and 8 - K available on the Investor Relations section of www.express-scripts.com.

The terms and conditions for this offer state: «Chase cardmembers who currently have or have had a Chase credit card in any Rewards Program associated with this offer, may not be eligible for a second Chase credit card in the same Rewards Program.»

This seems to be a new norm, which is why you can expect other online merchants to kick off loyalty programs with similar shipping conditions.

Many factors could cause BlackBerry's actual results, performance or achievements to differ materially from those expressed or implied by the forward - looking statements, including, without limitation: BlackBerry's ability to enhance its current products and services, or develop new products and services in a timely manner or at competitive prices, including risks related to new product introductions; risks related to BlackBerry's ability to mitigate the impact of the anticipated decline in BlackBerry's infrastructure access fees on its consolidated revenue by developing an integrated services and software offering; intense competition, rapid change and significant strategic alliances within BlackBerry's industry; BlackBerry's reliance on carrier partners and distributors; risks associated with BlackBerry's foreign operations, including risks related to recent political and economic developments in Venezuela and the impact of foreign currency restrictions; risks relating to network disruptions and other business interruptions, including costs, potential liabilities, lost revenues and reputational damage associated with service interruptions; risks related to BlackBerry's ability to implement and to realize the anticipated benefits of its CORE program; BlackBerry's ability to maintain or increase its cash balance; security risks; BlackBerry's ability to attract and retain key personnel; risks related to intellectual property rights; BlackBerry's ability to expand and manage BlackBerry ® World ™; risks related to the collection, storage, transmission, use and disclosure of confidential and personal information; BlackBerry's ability to manage inventory and asset risk; BlackBerry's reliance on suppliers of functional components for its products and risks relating to its supply chain; BlackBerry's ability to obtain rights to use software or components supplied by third parties; BlackBerry's ability to successfully maintain and enhance its brand; risks related to government regulations, including regulations relating to encryption technology; BlackBerry's ability to continue to adapt to recent board and management changes and headcount reductions; reliance on strategic alliances with third - party network infrastructure developers, software platform vendors and service platform vendors; BlackBerry's reliance on third - party manufacturers; potential defects and vulnerabilities in BlackBerry's products; risks related to litigation, including litigation claims arising from BlackBerry's practice of providing forward - looking guidance; potential charges relating to the impairment of intangible assets recorded on BlackBerry's balance sheet; risks as a result of actions of activist shareholders; government regulation of wireless spectrum and radio frequencies; risks related to economic and geopolitical conditions; risks associated with acquisitions; foreign exchange risks; and difficulties in forecasting BlackBerry's financial results given the rapid technological changes, evolving industry standards, intense competition and short product life cycles that characterize the wireless communications industry.

As for what Deming and company are looking for, she suggests the program is particularly interested in working with startups that are committed to addressing late - onset medical conditions relating to Alzheimer's, heart disease, diabetes and more.

In accordance with our policies, regulations and conditions, citizens of these countries can not take part in the crowdfunding program.

The SSA administers two programs for those with disabilities, serious medical conditions and severe financial hardship.

Examples of these risks, uncertainties and other factors include, but are not limited to the impact of: adverse general economic and related factors, such as fluctuating or increasing levels of unemployment, underemployment and the volatility of fuel prices, declines in the securities and real estate markets, and perceptions of these conditions that decrease the level of disposable income of consumers or consumer confidence; adverse events impacting the security of travel, such as terrorist acts, armed conflict and threats thereof, acts of piracy, and other international events; the risks and increased costs associated with operating internationally; our expansion into and investments in new markets; breaches in data security or other disturbances to our information technology and other networks; the spread of epidemics and viral outbreaks; adverse incidents involving cruise ships; changes in fuel prices and / or other cruise operating costs; any impairment of our tradenames or goodwill; our hedging strategies; our inability to obtain adequate insurance coverage; our substantial indebtedness, including the ability to raise additional capital to fund our operations, and to generate the necessary amount of cash to service our existing debt; restrictions in the agreements governing our indebtedness that limit our flexibility in operating our business; the significant portion of our assets pledged as collateral under our existing debt agreements and the ability of our creditors to accelerate the repayment of our indebtedness; volatility and disruptions in the global credit and financial markets, which may adversely affect our ability to borrow and could increase our counterparty credit risks, including those under our credit facilities, derivatives, contingent obligations, insurance contracts and new ship progress payment guarantees; fluctuations in foreign currency exchange rates; overcapacity in key markets or globally; our inability to recruit or retain qualified personnel or the loss of key personnel; future changes relating to how external distribution channels sell and market our cruises; our reliance on third parties to provide hotel management services to certain ships and certain other services; delays in our shipbuilding program and ship repairs, maintenance and refurbishments; future increases in the price of, or major changes or reduction in, commercial airline services; seasonal variations in passenger fare rates and occupancy levels at different times of the year; our ability to keep pace with developments in technology; amendments to our collective bargaining agreements for crew members and other employee relation issues; the continued availability of attractive port destinations; pending or threatened litigation, investigations and enforcement actions; changes involving the tax and environmental regulatory regimes in which we operate; and other factors set forth under «Risk Factors» in our most recently filed Annual Report on Form 10 - K and subsequent filings by the Company with the Securities and Exchange Commission.

Engage is linked with Anthem's suite of clinical and wellness programs, such as programs for expecting mothers or to help manage chronic conditions.

Conservatives think that a large federal government with expensive programs becomes a burden on society that actually can't be sustained and creates worse conditions in the long run.

Introduction The National Council of the Churches of Christ in the USA, through its programs of mission and witness, seeks to join with others in defining and creating the conditions for a more just world order.

Though the power of determination of the specific content on television remains with the local station management, the FCC has on different occasions offered suggestions on the types of programming that should be present in a station's schedule in order for the station to fulfill the conditions of its license.

He was intently concerned with the careful identification and accurate tracking of preferred behaviors, with deliberate scheduling of realistic behavior change objectives, with accurate measurement of incremental changes, with deliberately programmed steps of behavior change, and, at selected times, with aversive conditioning.18

I do nt think we are all born with an innate sense of right and wrong, we are wired differently and our conditioning can program us to walk through life with blinders on not seeing how immoral and wrong our behavior is... I loved this story.

Behavioral modification programs using aversive therapy have conditioned some homosexuals against attraction to their own sex, but most frequently they have been unable to replace that with attraction to the opposite sex, a dehumanizing result.

Port au Prince typically doesn't get hit directly by the hurricanes, but often gets a lot of the rain from them, so having improved sanitary conditions in camps that could be prone to flooding could be really helpful, digging ditches in the camps, these are all cash - for - work programs that could help with some of the rain that could come in the coming months.

While a healthy diet, limiting sugar and artificial ingredients, and structured programs are all recommended to assist with the treatment of the condition, the truth is that coping with autism on your own can often be very difficult, regardless of whether it is you or a loved one facing...

USDA National Organic Program: «A variety of methods used to genetically modify organisms or influence their growth and development by means that are not possible under natural conditions or processes and are not considered compatible with organic production, (are not allowed).

Ben & Jerry's has agreed to implement the Milk with Dignity (MD) Program, a multi-year plan created by Migrant Justice in 2014, which aims to improve working conditions of dairy farm workers who supply the milk for the ice cream manufacturer.

The Medical Treatment Overseas Program (MTOP) provides financial assistance for Australians with a life - threatening medical condition to receive proven life saving medical treatment overseas where effective treatment is not available in Australia.

We've helped thousands of people heal their debilitating health conditions though our proven 3 - phase program and invite you to do the same with our online Elimination Diet Support Pprogram and invite you to do the same with our online Elimination Diet Support ProgramProgram.

To counter them, he ratcheted up his summer conditioning program and spent the preseason preparing to play both guard positions as well as small forward to better mesh with All - Star center Yao Ming.

With no football, a non-ESPN television contract, and a handful of programs still attached with an unwanted «mid-major» stigma, it was a very realistic possibility that this sink or swim condition would end with Villanova and company discovering what the bottom of the college athletics pool feels lWith no football, a non-ESPN television contract, and a handful of programs still attached with an unwanted «mid-major» stigma, it was a very realistic possibility that this sink or swim condition would end with Villanova and company discovering what the bottom of the college athletics pool feels lwith an unwanted «mid-major» stigma, it was a very realistic possibility that this sink or swim condition would end with Villanova and company discovering what the bottom of the college athletics pool feels lwith Villanova and company discovering what the bottom of the college athletics pool feels like.

In Shanahan's first - floor office, with the practice fields outside his window (at one point, in an early phase of the off - season strength and conditioning program, a group of players including quarterbacks Brian Hoyer and Matt Barkley stretched out on the field), he and Lynch studied candidates; Marathe and vice president of player personnel Adam Peters filtered in and out, in between projects and calls.

With a year or two in an NFL strength and conditioning / speed program, he could be a solid edge setter.

A comprehensive strength and conditioning program starts with assessing the athlete's sporting and injury history and current pathology (if there is any).

Publish is required to comply with terms and conditions of our contribution program.

Working with Ben Herbert, the Michigan football program's new director of strength and conditioning, has energized the running back.

From Harvard, a recent study by Dr. Elizabeth Hoge, a psychiatrist at the Center for Anxiety and Traumatic Stress Disorders at Massachusetts General Hospital and an assistant professor of psychiatry at Harvard Medical School, found that «a mindfulness - based stress reduction program helped quell anxiety symptoms in people with generalized anxiety disorder, a condition marked by hard - to - control worries, poor sleep, and irritability.»

Contrary to what you may have been reading, however, the exercise by municipalities of the power of the permit to require private sports programs to comply with state - mandated concussion safety laws, or impose additional conditions beyond those required by state law, isn't an isolated or new phenomenon: it's been a growing trend for years.

If you are involved in a private youth sports program which plays on publicly - owned fields, diamonds, rinks, or courts, or are in local government, you have probably been hearing a lot lately about what is being dubbed the «power of the permit»: the authority municipalities and towns around the country are using to condition use of their athletic facilities by private programs on compliance with state concussion safety laws from which they would otherwise be exempt, or, in an increasing number of instances, to fill gaps in their state's law.

While helmets do not prevent concussions, replacing helmets that have reached or exceeded their useful life is an important step to keep young football players safe, especially as the replacement program will be combined with a strong educational campaign on concussion awareness, proper helmet fitting, and instruction on proper tackling, and receipt of the new helmets will be conditioned on coaches completing USA Football's basic coaching course.

With a robust knowledge of breastfeeding tips, and other health issues that can disrupt a successful breastfeeding program as presented in this classical videos, you will learn that mastitis is a health condition peculiar to the mammary organs in lactating moms, due to an attack by bacteria and wrong positioning of the breasts while sleeping or wearing a bra.

The National Athletic Trainers» Association 2014 position statement on the management of sport - related concussion [14] says all athletes should «ideally» undergo a preseason baseline assessment, but, that, at a minimum, athletes who are at a high risk of concussion based on their sport should be included in any baseline testing program, with athletes with a significant concussion history, or other relevant pre-existing condition, such as attention - deficit hyperactivity disorder, tested on an individual basis.

Additional research on the replication and scale - up of home visiting programs should be conducted to identify the conditions, processes, and supports associated with achieving and sustaining high - fidelity implementation.

Research has demonstrated that a large proportion of mothers served in home visiting suffer from mental health problems, with up to 50 percent experiencing clinically elevated levels of depression during the critical first years of their child's development.5 There is evidence that many depressed mothers fail to fully benefit from home visiting.6 Identifying depressed mothers or those at risk for depression who are participating in home visiting, and treating or preventing the condition and its deleterious consequences, can improve program outcomes and foster healthy child development.

When expectant parents learn that their fetus has been diagnosed with a high - risk condition, our Fetal and Pregnancy Health Program brings together a unique team of experts to address the needs of both mother and baby before, during and after delivery.